Cvs Berry Antacid Heartburn and Gas

Description

CVS Mixed Berry Antacid is formulated as a chewable tablet, available in a package containing 28 count. The product is designed to provide relief from heartburn and indigestion. It features a mixed berry flavor, enhancing palatability for users. The active ingredients work to neutralize stomach acid, contributing to its antacid properties.

Uses and Indications

This drug is indicated for the relief of heartburn, sour stomach, and acid indigestion. It is also effective in alleviating upset stomach associated with these symptoms. Additionally, this medication provides relief from bloating, pressure, or a stuffed feeling commonly referred to as gas.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and older are advised to chew and swallow 1 to 2 chewable tablets every 2 to 4 hours as needed for symptom relief. The total daily dosage should not exceed 5 chewable tablets within a 24-hour period.

For children under 12 years of age, it is recommended to consult a healthcare professional prior to administration to determine appropriate dosing and safety.

Contraindications

The product should not be used at the maximum dosage for more than 2 weeks unless advised and supervised by a physician. This limitation is in place to mitigate potential risks associated with prolonged high-dose use. No other contraindications have been specified in the provided data.

Warnings and Precautions

The use of this product is contraindicated in individuals with a known history of allergic reactions to the product or any of its components. Healthcare professionals should ensure that patients are screened for such allergies prior to administration.

Caution is advised regarding the duration of use. The maximum dosage should not be exceeded for more than two weeks unless specifically directed and monitored by a physician. Prolonged use at maximum dosage may lead to adverse effects that require medical oversight.

Patients should be informed that the use of this product may result in constipation. It is essential for healthcare providers to counsel patients on the potential for this side effect and to monitor for its occurrence during treatment.

Currently, there are no specific laboratory tests recommended for monitoring the safe use of this product. However, healthcare professionals should remain vigilant for any signs of adverse reactions or complications that may arise during treatment.

Side Effects

Patients should be aware that the use of this product is contraindicated in individuals who have a history of allergic reactions to the product or any of its ingredients.

In clinical trials and postmarketing experiences, adverse reactions have been reported; however, specific data regarding the frequency and nature of these reactions were not provided in the extracted information. It is essential for patients to consult healthcare professionals for further information regarding potential adverse reactions and to report any unexpected symptoms following the use of this product.

Drug Interactions

Antacids may interact with various prescription medications, potentially affecting their absorption and efficacy. It is advisable to monitor the timing of antacid administration in relation to other medications to minimize these interactions. Patients should be counseled to separate the dosing of antacids and other prescribed drugs by at least two hours when possible to ensure optimal therapeutic outcomes.

Packaging & NDC

Below are the non-prescription pack sizes of Cvs Berry Antacid Heartburn and Gas (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents aged 12 years and older, the recommended dosage is 1 to 2 chewable tablets taken every 2 to 4 hours as needed, with a maximum of 5 chewable tablets in a 24-hour period.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers can offer guidance tailored to individual circumstances, ensuring the safety of both the patient and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as indicated based on the clinical scenario and the substance involved. Consultation with a poison control center or a medical toxicologist may be beneficial for guidance on management strategies tailored to the specific situation.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Reports of adverse events have been received through voluntary reporting and surveillance programs. Healthcare professionals and patients are encouraged to report any adverse events to the designated contact number, 1-800-245-2898. This information contributes to the ongoing monitoring of the product's safety profile.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion.

Patients should be informed not to exceed the maximum dosage for more than two weeks unless directed by a physician. It is important for patients to understand the potential for constipation when using this product, and they should be encouraged to monitor their bowel habits.

Additionally, healthcare providers should recommend that patients consult with a doctor or pharmacist before using this product if they are currently taking any prescription medications. This is particularly crucial as antacids may interact with certain prescription drugs, and professional guidance can help avoid any adverse effects.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which are essential for identification and inventory management. It is crucial to store the product in a controlled environment, maintaining a temperature range of 20° to 25°C (68° to 77°F). The storage area should be dry to ensure the integrity of the product. Proper handling and storage conditions are vital to preserve the quality and efficacy of the product throughout its shelf life.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Cvs Berry Antacid Heartburn and Gas, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)